Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Fund Manager results
Tips from these results
Recent Share tips:
- Buy British American Tobacco (BATS) by Charlie Keough in The Motley Fool
- Sector Perform Unilever (ULVR) by RBC Capital
- Buy Anglo Asian Mining (AAZ) by Hot Stock Rockets in ShareProphets
- Buy Croda International (CRDA) by UBS
- Avoid Videndum (VID) by Steve Moore in ShareProphets
- Buy Reckitt Benckiser Group (RKT) by DZ Bank
- Add National Grid (NG.) by Mark David Hartley in The Motley Fool
- Neutral WPP (WPP) by JP Morgan
- Sell Centamin (DI) (CEY) by Liberum Capital
- Watch Burberry Group (BRBY) by Harvey Jones in The Motley Fool
- Hold Reckitt Benckiser Group (RKT) by Berenberg
- Overweight Diploma (DPLM) by Barclays
- Overweight Reckitt Benckiser Group (RKT) by Barclays
- Underweight Abrdn (ABDN) by Barclays
- Outperform Jet2 (JET2) by RBC Capital
- Buy THG (THG) by HSBC
- Hold Reckitt Benckiser Group (RKT) by HSBC
- Buy Centrica (CNA) by Goldman Sachs
- Buy Anglo American (AAL) by Jefferies
- Buy Allianz Technology Trust (ATT) by Lauren Almeida in The Times - Tempus
Allergy Therapeutics (AGY) Share Price
Health Care Sector
NOTE: This is based on 22 open tips for Allergy Therapeutics (AGY)
| Latest Bid : 2.80p | Latest Ask : 2.90p |
| High Today : 2.90p | Low Today : 2.80p |
| This Years High : 6.25p | This Years Low : 0.88p |
| Volume : 260,349 | MKT Cap : £138.21M |
| Trading Velocity : Premium Only | Activity Score : Premium Only |
| Consensus Score : Premium Only | Momentum Score : Premium Only |
Allergy Therapeutics (AGY) Overview
We are a market leading, pioneering immunology business with specialist experience in the research and development of allergy treatments. We believe that transformational outcomes for patients are achieved by directly treating the cause, rather than just managing symptoms. Our vaccines are aluminium free. Driving convenience; our ultra-short course treatments make life easier and increase adherence.Allergy Therapeutics (AGY) Latest Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Corporate | FinnCap | Premium Only | 2019-03-22 10:10:00 22/03/2019 | – |
| Hold | Tempus Editors | Premium Only | 2019-03-19 00:05:00 19/03/2019 | 192.45% |
| Corporate | FinnCap | Premium Only | 2019-03-06 09:25:00 06/03/2019 | – |
| Buy | Numis | Premium Only | 2018-09-26 08:30:00 26/09/2018 | -47.55% |
| Buy | Numis | Premium Only | 2018-07-19 11:05:00 19/07/2018 | -7.27% |
Allergy Therapeutics (AGY) Active Short Positions
| Fund Manager | Position | Date | ||
|---|---|---|---|---|
| No active short positions | ||||
| Latest Bid : 2.80p | Latest Ask : 2.90p |
| High Today : 2.90p | Low Today : 2.80p |
| This Years High : 6.25p | This Years Low : 0.88p |
| Volume : 260,349 | MKT Cap : £138.21M |
Allergy Therapeutics Overview
We are a market leading, pioneering immunology business with specialist experience in the research and development of allergy treatments. We believe that transformational outcomes for patients are achieved by directly treating the cause, rather than just managing symptoms. Our vaccines are aluminium free. Driving convenience; our ultra-short course treatments make life easier and increase adherence.NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.
Latest Allergy Therapeutics Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Corporate | FinnCap | Premium Only | 2019-03-22 10:10:00 22/03/2019 | – |
| Hold | Tempus Editors | Premium Only | 2019-03-19 00:05:00 19/03/2019 | 192.45% |
| Corporate | FinnCap | Premium Only | 2019-03-06 09:25:00 06/03/2019 | – |
| Buy | Numis | Premium Only | 2018-09-26 08:30:00 26/09/2018 | -47.55% |
| Buy | Numis | Premium Only | 2018-07-19 11:05:00 19/07/2018 | -7.27% |